StockpollyBeta
Get App
Popularity #427
DHR · NYSE · Medical - Diagnostics & Research

Danaher (DHR)

Supplies bioprocessing, life-science, and diagnostic tools with recurring consumables and service.

$222.06
vs last close+6.22 (+2.88%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue5,6246,4055,7965,7435,7986,5385,7415,9366,0536,8385,9516,265
Cost of revenue2,3492,6262,3092,3152,3972,6482,2301,9812,5302,8722,3602,654
Gross profit3,2753,7793,4873,4283,4013,8903,5113,9553,5233,9663,5913,611
2,0902,3652,1752,2602,4432,1442,2372,7632,3692,4642,2472,484
Research & development362407368391383442379403378438387412
1,7281,9581,8071,8692,0601,7021,8582,3601,9912,0261,8602,072
Selling & marketing000000000002,072
General & administrative00000000001,8600
Operating income1,1851,4141,3121,1689581,7461,2741,1921,1541,5021,3441,127
−38−182−41−8519−431−145−537−78−129−109−49
Interest income791176039414683132761
Interest expense7085656587617271675563−107
Other non-operating income−3297−2420−10637073466117446−58
Income before tax1,1471,2321,2711,0839771,3151,1296551,0761,3731,2351,078
Income tax expense207111183176159229175100168176206208
Net income from continuing operations9401,1211,0889078181,0869545559081,1971,029870
Discontinued operations189−420000000000
Net income1,1291,0791,0889078181,0869545559081,1971,029870
EPS, basic$1.53$1.46$1.47$1.23$1.13$1.50$1.33$0.77$1.28$1.69$1.45$1.23
EPS, diluted$1.51$1.45$1.45$1.22$1.12$1.49$1.32$0.77$1.27$1.68$1.45$1.23
Weighted average shares, basic739740741738723731716717711707708705
Weighted average shares, diluted746746749742729737721719714711711708
EBITDA1,7061,8101,9221,7281,6551,9711,7921,3371,7652,0511,4911,844
Depreciation & amortization489493586580591595591611622623193659
EBIT1,2171,3171,3361,1481,0641,3761,2017261,1431,4281,2981,185